Product Information
VALSARTAN 80 MG TABLET is a generic product labeled by Archis Pharma LLC, priced at $0.0891 per EA under NDC 72819018209. Its NADAC has been published 177 times since Apr 5, 2023.
FDA first approved this application on Apr 9, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the valsartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
80 mg/1
Manufacturer
Archis Pharma LLCNDC
72819018209
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA205347FDA Approved
4/9/2018
TE Code
AB
On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN 80 MG TABLET has been published 177 times since Apr 5, 2023, and over the history we have for it it has declined 50.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0891 per EA |
|---|---|
| All-time high | $0.1784 (Apr 12, 2023) |
| All-time low | $0.0891 (Aug 19, 2026) |
| 52-week high | $0.1270 |
| 52-week low | $0.0891 |
| Median price | $0.1292 |
| Average price | $0.1344 |
| Largest weekly change | -25.7% (Apr 17, 2024) |
| Weeks tracked | 177 |
| Tracking since | Apr 5, 2023 |
1W
N/A
1M
N/A
3M
-15.4%
6M
-21.2%
1Y
-29.2%
3Y
-39.3%
5Y
N/A
All
-50.0%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Archis Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
valsartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALSARTAN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN 80 MG TABLET, manufactured by Archis Pharma LLC, is $0.0891 per EA (NDC 72819018209), effective Aug 19, 2026.
How has the price of VALSARTAN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALSARTAN 80 MG TABLET has declined 50.0%. It has been tracked across 177 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for VALSARTAN 80 MG TABLET?
Since Apr 5, 2023, the NADAC for VALSARTAN 80 MG TABLET has ranged from a low of $0.0891 (Aug 19, 2026) to a high of $0.1784 (Apr 12, 2023), with a median of $0.1292 per EA.
Are there cheaper alternatives to VALSARTAN 80 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VALSARTAN 80 MG TABLET, is $0.0820 per EA — about 8% below VALSARTAN 80 MG TABLET.
Who manufactures VALSARTAN 80 MG TABLET?
VALSARTAN 80 MG TABLET (NDC 72819018209) is labeled by Archis Pharma LLC, and CMS classifies it as a generic product.